Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,584 | Dovepress* | 8,563+ | 909 | 9,472 | |
PubMed Central* | 1,021 | 361 | 1,382 | ||
Totals | 9,584 | 1,270 | 10,854 | ||
*Since 15 October 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 1 | 0 | 5 |
View citations on PubMed Central and Google Scholar